{"id":11303,"date":"2022-07-01T20:31:38","date_gmt":"2022-07-02T00:31:38","guid":{"rendered":"https:\/\/www.cancerresearch.org\/event\/aiming-the-immune-system-at-brain-cancer\/"},"modified":"2022-07-14T16:01:57","modified_gmt":"2022-07-14T20:01:57","slug":"aiming-the-immune-system-at-brain-cancer","status":"publish","type":"cri_events","link":"https:\/\/www.cancerresearch.org\/es\/events\/aiming-the-immune-system-at-brain-cancer","title":{"rendered":"Aiming the Immune System at Brain Cancer"},"content":{"rendered":"<p style=\"text-align: center;\"><iframe loading=\"lazy\" allowfullscreen=\"\" frameborder=\"0\" height=\"360\" src=\"https:\/\/www.youtube.com\/embed\/VYLoiMJFCq4\" width=\"640\"><\/iframe><\/p>\n<p>In this webinar designed for patients and caregivers, David A. Reardon, MD, discussed current immunotherapy treatment options for patients with brain cancer, and how close we are to making these treatments available to more patients.<\/p>\n<p>David A. Reardon, MD, currently serves as Clinical Director of the Center for Neuro-Oncology at the Dana-Farber Cancer Institute and previously served as the Associate Deputy Director of the Preston Robert Tisch Brain Tumor Center at Duke University Medical Center. His work includes using innovative clinical therapies to improve cure rates in patients with brain and spinal tumors, with particular focus on immunotherapies.<\/p>\n<p>This webinar is part of the Cancer Research Institute&#39;s webinar series, &quot;Cancer Immunotherapy and You,&quot; which are offered free to the public and feature informative updates for patients and caregivers from leaders in cancer immunotherapy, followed by a Q&amp;A. This webinar was generously supported by Agenus.&nbsp;For more information on this webinar, or to register for upcoming webinars, please visit <a href=\"https:\/\/www.cancerresearch.org\/webinars\" target=\"_blank\" rel=\"noopener\">www.cancerresearch.org\/webinars<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Dr. David A. Reardon of&nbsp;Dana-Farber Cancer Institute discusses current immunotherapy options for patients with brain cancer.<\/p>\n","protected":false},"featured_media":2330,"template":"","events_categories":[198],"resource_cancer_types":[],"resource_patient_age":[],"resource_cancer_stage":[],"resource_treatment_type":[],"resource_treatment_status":[],"class_list":["post-11303","cri_events","type-cri_events","status-publish","has-post-thumbnail","hentry","events_categories-webinars"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Aiming the Immune System at Brain Cancer<\/title>\n<meta name=\"description\" content=\"Dr. David A. Reardon of\u00a0Dana-Farber Cancer Institute discusses current immunotherapy options for patients with brain cancer.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cancerresearch.org\/events\/aiming-the-immune-system-at-brain-cancer\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Aiming the Immune System at Brain Cancer\" \/>\n<meta property=\"og:description\" content=\"Dr. David A. Reardon of\u00a0Dana-Farber Cancer Institute discusses current immunotherapy options for patients with brain cancer.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cancerresearch.org\/events\/aiming-the-immune-system-at-brain-cancer\" \/>\n<meta property=\"og:site_name\" content=\"Cancer Research Institute\" \/>\n<meta property=\"article:modified_time\" content=\"2022-07-14T20:01:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/b966a2f7-4dc4-4f7f-9e77-d5a9ea8ca22d.jpg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Aiming the Immune System at Brain Cancer\" \/>\n<meta name=\"twitter:description\" content=\"Dr. David A. Reardon of\u00a0Dana-Farber Cancer Institute discusses current immunotherapy options for patients with brain cancer.\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/b966a2f7-4dc4-4f7f-9e77-d5a9ea8ca22d.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cancerresearch.org\/events\/aiming-the-immune-system-at-brain-cancer\",\"url\":\"https:\/\/www.cancerresearch.org\/events\/aiming-the-immune-system-at-brain-cancer\",\"name\":\"Aiming the Immune System at Brain Cancer\",\"isPartOf\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.cancerresearch.org\/events\/aiming-the-immune-system-at-brain-cancer#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/events\/aiming-the-immune-system-at-brain-cancer#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/449011d2-d277-4b03-935a-bd90a059abe2.jpg\",\"datePublished\":\"2022-07-02T00:31:38+00:00\",\"dateModified\":\"2022-07-14T20:01:57+00:00\",\"description\":\"Dr. David A. Reardon of\u00a0Dana-Farber Cancer Institute discusses current immunotherapy options for patients with brain cancer.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.cancerresearch.org\/events\/aiming-the-immune-system-at-brain-cancer#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cancerresearch.org\/events\/aiming-the-immune-system-at-brain-cancer\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/events\/aiming-the-immune-system-at-brain-cancer#primaryimage\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/449011d2-d277-4b03-935a-bd90a059abe2.jpg\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/449011d2-d277-4b03-935a-bd90a059abe2.jpg\",\"width\":320,\"height\":208},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cancerresearch.org\/events\/aiming-the-immune-system-at-brain-cancer#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.cancerresearch.org\/es\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Event\",\"item\":\"https:\/\/www.cancerresearch.org\/events\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Aiming the Immune System at Brain Cancer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cancerresearch.org\/#website\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"name\":\"Cancer Research Institute\",\"description\":\"For a World Immune to Cancer\",\"publisher\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cancerresearch.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\",\"name\":\"Cancer Research Institute\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"width\":156,\"height\":53,\"caption\":\"Cancer Research Institute\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Aiming the Immune System at Brain Cancer","description":"Dr. David A. Reardon of\u00a0Dana-Farber Cancer Institute discusses current immunotherapy options for patients with brain cancer.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cancerresearch.org\/events\/aiming-the-immune-system-at-brain-cancer","og_locale":"es_ES","og_type":"article","og_title":"Aiming the Immune System at Brain Cancer","og_description":"Dr. David A. Reardon of\u00a0Dana-Farber Cancer Institute discusses current immunotherapy options for patients with brain cancer.","og_url":"https:\/\/www.cancerresearch.org\/events\/aiming-the-immune-system-at-brain-cancer","og_site_name":"Cancer Research Institute","article_modified_time":"2022-07-14T20:01:57+00:00","og_image":[{"url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/b966a2f7-4dc4-4f7f-9e77-d5a9ea8ca22d.jpg","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_title":"Aiming the Immune System at Brain Cancer","twitter_description":"Dr. David A. Reardon of\u00a0Dana-Farber Cancer Institute discusses current immunotherapy options for patients with brain cancer.","twitter_image":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/b966a2f7-4dc4-4f7f-9e77-d5a9ea8ca22d.jpg","twitter_misc":{"Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.cancerresearch.org\/events\/aiming-the-immune-system-at-brain-cancer","url":"https:\/\/www.cancerresearch.org\/events\/aiming-the-immune-system-at-brain-cancer","name":"Aiming the Immune System at Brain Cancer","isPartOf":{"@id":"https:\/\/www.cancerresearch.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cancerresearch.org\/events\/aiming-the-immune-system-at-brain-cancer#primaryimage"},"image":{"@id":"https:\/\/www.cancerresearch.org\/events\/aiming-the-immune-system-at-brain-cancer#primaryimage"},"thumbnailUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/449011d2-d277-4b03-935a-bd90a059abe2.jpg","datePublished":"2022-07-02T00:31:38+00:00","dateModified":"2022-07-14T20:01:57+00:00","description":"Dr. David A. Reardon of\u00a0Dana-Farber Cancer Institute discusses current immunotherapy options for patients with brain cancer.","breadcrumb":{"@id":"https:\/\/www.cancerresearch.org\/events\/aiming-the-immune-system-at-brain-cancer#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cancerresearch.org\/events\/aiming-the-immune-system-at-brain-cancer"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/events\/aiming-the-immune-system-at-brain-cancer#primaryimage","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/449011d2-d277-4b03-935a-bd90a059abe2.jpg","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/449011d2-d277-4b03-935a-bd90a059abe2.jpg","width":320,"height":208},{"@type":"BreadcrumbList","@id":"https:\/\/www.cancerresearch.org\/events\/aiming-the-immune-system-at-brain-cancer#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cancerresearch.org\/es"},{"@type":"ListItem","position":2,"name":"Event","item":"https:\/\/www.cancerresearch.org\/events"},{"@type":"ListItem","position":3,"name":"Aiming the Immune System at Brain Cancer"}]},{"@type":"WebSite","@id":"https:\/\/www.cancerresearch.org\/#website","url":"https:\/\/www.cancerresearch.org\/","name":"Cancer Research Institute","description":"For a World Immune to Cancer","publisher":{"@id":"https:\/\/www.cancerresearch.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cancerresearch.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cancerresearch.org\/#organization","name":"Cancer Research Institute","url":"https:\/\/www.cancerresearch.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","width":156,"height":53,"caption":"Cancer Research Institute"},"image":{"@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/cri_events\/11303","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/cri_events"}],"about":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/types\/cri_events"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media\/2330"}],"wp:attachment":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media?parent=11303"}],"wp:term":[{"taxonomy":"events_categories","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/events_categories?post=11303"},{"taxonomy":"resource_cancer_types","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_cancer_types?post=11303"},{"taxonomy":"resource_patient_age","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_patient_age?post=11303"},{"taxonomy":"resource_cancer_stage","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_cancer_stage?post=11303"},{"taxonomy":"resource_treatment_type","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_treatment_type?post=11303"},{"taxonomy":"resource_treatment_status","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_treatment_status?post=11303"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}